Showing results (1111-1120 of 1,398) with videos related to

Sort By:
Pageof 140
Drug Development Research|February 5, 2025
Discovery of Hydrazine Clubbed Thiazoles as Potential Antidiabetic Agents: Synthesis, Biological Evaluation, and Molecular Docking StudiesBetül Kaya, Hakan Tahtacı, Bilge Çiftçi, et al.
Drug Development Research|February 5, 2025
Experimentation of Heterocycles (2013-22) as Potent Pharmacophores in Drug Design of Multiple SclerosisAtukuri Dorababu
Drug Development Research|January 12, 2025
Current Strategies and Future Dimensions in the Development of KRAS Inhibitors for Targeted Anticancer TherapyLaura D'Alessio-Sands, Joshua Gaynier, Victoria Michel-Milian, et al.
Drug Development Research|January 3, 2025
An Inducible Neural Stem Progenitor Cell Model for Testing Therapeutic Interventions Against Neurodegeneration FENIBAlessandro Giustini, Alice Maiocchi, Ilaria Serangeli, et al.
Drug Development Research|December 26, 2024
Sulfamethizole Attenuates Pentylenetetrazole-Induced Seizures in Mice via mTOR InhibitionLazari Kambli, Dezaree Raut, Lokesh Kumar Bhatt
Drug Development Research|December 26, 2024
Orthoallosteric EGFR-TKIs: A New Paradigm in NSCLC Treatment Strategy Targeting the C797S MutationIqrar Ahmad, Harun M Patel
Drug Development Research|December 5, 2024
Anxiolytic Effect of Sesamol, Possibly Through the GABAkine Interaction PathwayMd Tahajul Islam, Abdul Malik, Abdullah K Alshememry, et al.
Drug Development Research|December 24, 2024
Phthalazine Derivatives as VEGFR-2 Inhibitors: Docking, ADMET, Synthesis, Design, Anticancer Evaluations, and Apoptosis InducersHatem Hussein Bayoumi, Mohamed-Kamal Ibrahim, Mohammed A Dahab, et al.
Drug Development Research|December 13, 2024
AEBP1 Silencing Protects Against Cerebral Ischemia/Reperfusion Injury by Regulating Neuron Ferroptosis and Microglia M2 Polarization Through PRKCA-PI3K-Akt AxisYafen Zhang, Yan Li, Fengli Liu
Drug Development Research|December 10, 2024
Does Metabolic Manager Show Encouraging Outcomes in Alzheimer's?: Challenges and Opportunity for Protein Tyrosine Phosphatase 1b InhibitorsRitu Singh, Smita Jain, Vartika Paliwal, et al.
Pageof 140